Skip to main content

Table 1 Demographic and clinical parameters

From: Role of MR-proADM in the risk stratification of COVID-19 patients assessed at the triage of the Emergency Department

 

Overall

Survivors

Non-survivors

P value

N = 321

N = 224

N = 97

Age

Years, mean (SD)

63.3 (14.7)

59.6 (14.6)

71.9 (11.2)

 < 0.001

Sex

Male, N (%)

215 (67.0)

145 (64.7)

70 (72.2)

0.193

Female, N (%)

106 (33.0)

79 (35.3)

27 (27.8)

 

Comorbidities

Hypertension, N (%)

131 (40.8)

70 (31.3)

61 (62.9)

 < 0.001

Diabetes, N (%)

42 (13.1)

19 (8.5)

23 (23.7)

 < 0.001

Respiratory disease, N (%)

28 (8.7)

14 (6.3)

14 (14.4)

0.017

Malignancy, N (%)

19 (5.9)

10 (4.5)

9 (9.3)

0.093

Cardiovascular disease, N (%)

55 (17.1)

27 (12.1)

28 (28.9)

 < 0.001

Renal disease, N (%)

51 (15.9)

13 (5.8)

38 (39.2)

 < 0.001

Obesity, N (%)

15 (4.7)

8 (3.6)

7 (7.2)

0.155

  1. Values expressed in percentages (%) indicate the proportion of patients within each group for each variable. Data are presented as mean (standard deviation, SD) where specified. The Chi-square (χ2) test was used to determine significance between the groups for categorical variables, Student’s t test for the variable of age
Back to article page

Critical Care

ISSN: 1364-8535